Dalton Pharmaceuticals

Dalton Pharma Services is a leading North American contract development and manufacturing organization (CDMO) that provides integrated drug discovery, development, and manufacturing services. Founded in 1986 and headquartered in Toronto, Canada, the company supports pharmaceutical and biotechnology clients through all stages of drug development. Their core competencies include medicinal chemistry, cGMP API manufacturing, formulation development, and sterile fill-finish for both clinical and commercial supplies. Dalton specializes in complex chemistry, including the production of peptides and oligonucleotides. In 2024, the company was acquired by Eurofarma, a major Latin American pharmaceutical corporation, to enhance its global R&D and manufacturing capabilities.